Sarah Appleby

493 total citations
21 papers, 356 citations indexed

About

Sarah Appleby is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sarah Appleby has authored 21 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sarah Appleby's work include Heart Failure Treatment and Management (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Sarah Appleby is often cited by papers focused on Heart Failure Treatment and Management (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Sarah Appleby collaborates with scholars based in New Zealand, Singapore and United Kingdom. Sarah Appleby's co-authors include Nicholas W. Morrell, Paul D. Upton, Mark Southwood, Alexi Crosby, Edwin R. Chilvers, Mark Richards, Janice Chew‐Harris, Tamara Tajsic, Joanna Pepke‐Żaba and Kenneth D. Bloch and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Sarah Appleby

20 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Appleby New Zealand	9	138	101	54	50	49	21	356
Malvina A. Krupiczojc United Kingdom	4	223 1.6×	79 0.8×	40 0.7×	40 0.8×	30 0.6×	5	409
Qiang Song China	8	74 0.5×	72 0.7×	36 0.7×	29 0.6×	41 0.8×	19	260
Claudia Bonino Italy	9	113 0.8×	62 0.6×	85 1.6×	22 0.4×	64 1.3×	10	330
Katrina Ashworth United States	10	86 0.6×	55 0.5×	90 1.7×	74 1.5×	33 0.7×	19	380
Chiara Calabrese Italy	13	59 0.4×	114 1.1×	32 0.6×	100 2.0×	98 2.0×	22	361
David Santer Austria	10	94 0.7×	57 0.6×	44 0.8×	149 3.0×	40 0.8×	36	329
Claudie Bantsimba-Malanda France	6	184 1.3×	61 0.6×	85 1.6×	25 0.5×	25 0.5×	8	354
Małgorzata Michalska‐Jakubus Poland	14	58 0.4×	142 1.4×	70 1.3×	22 0.4×	59 1.2×	33	394
Luisa Ojeda‐Fernández Italy	13	119 0.9×	96 1.0×	30 0.6×	34 0.7×	18 0.4×	23	396
Krzysztof Kowal Poland	12	124 0.9×	76 0.8×	92 1.7×	24 0.5×	31 0.6×	27	385

Countries citing papers authored by Sarah Appleby

Since Specialization

Citations

This map shows the geographic impact of Sarah Appleby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Appleby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Appleby more than expected).

Fields of papers citing papers by Sarah Appleby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Appleby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Appleby. The network helps show where Sarah Appleby may publish in the future.

Co-authorship network of co-authors of Sarah Appleby

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Appleby. A scholar is included among the top collaborators of Sarah Appleby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Appleby. Sarah Appleby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Appleby, Sarah & Rachel Purcell. (2025). Circulating bacterial DNA in cardiovascular disease. Frontiers in Cardiovascular Medicine. 12. 1476165–1476165. 1 indexed citations

Appleby, Sarah, et al.. (2024). Cardiac effects of myoregulin in ischemia-reperfusion. Peptides. 174. 171156–171156. 2 indexed citations

Chew‐Harris, Janice, Chris Frampton, Sarah Appleby, et al.. (2024). Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessness. International Journal of Cardiology. 406. 132071–132071. 4 indexed citations

Paton, Louise N., et al.. (2024). CNDP2: An Enzyme Linking Metabolism and Cardiovascular Diseases?. Journal of Cardiovascular Translational Research. 18(1). 48–57. 2 indexed citations

Appleby, Sarah, Chris Frampton, M. A. Holdaway, et al.. (2024). Circulating erythroferrone has diagnostic utility for acute decompensated heart failure in patients presenting with acute or worsening dyspnea. Frontiers in Cardiovascular Medicine. 10. 1195082–1195082. 1 indexed citations

Chew‐Harris, Janice, Win Sen Kuan, Irwani Ibrahim, et al.. (2022). Comparative performances of soluble urokinase plasminogen activator receptor and Mid-regional proADM to predict composite death and new heart failure rehospitalisation in acutely breathless patients. European Heart Journal. 43(Supplement_2). 1 indexed citations

Lewis, Lynley K., et al.. (2022). Assays Specific for BNP1-32 and NT-proBNP Exhibit a Similar Performance to Two Widely Used Assays in the Diagnosis of Heart Failure. Clinical Chemistry. 68(10). 1292–1301. 3 indexed citations

Chew‐Harris, Janice, et al.. (2021). Soluble Urokinase Plasminogen Activator Receptor (suPAR) Predicts Mortality in Patients With Acute Chest Pain. Heart Lung and Circulation. 30. S86–S86. 1 indexed citations

Holdaway, M. D., et al.. (2021). Erythroferrone can Diagnose Acute Decompensated Heart Failure in Patients Presenting With Breathlessness. Heart Lung and Circulation. 30. S76–S76.

10.

Appleby, Sarah, et al.. (2020). Analytical and biological assessment of circulating human erythroferrone. Clinical Biochemistry. 79. 41–47. 16 indexed citations

11.

Chew‐Harris, Janice, et al.. (2020). Soluble urokinase plasminogen activator receptor (suPAR) can predict long-term mortality in patients with acute chest pain. European Heart Journal. 41(Supplement_2). 1 indexed citations

12.

Chew‐Harris, Janice, et al.. (2019). Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals. Clinical Biochemistry. 69. 36–44. 32 indexed citations

13.

Appleby, Sarah, Gerard B. Nash, Ziad Mallat, et al.. (2017). Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2. Journal of Biological Chemistry. 292(33). 13714–13726. 44 indexed citations

14.

Farahi, Neda, Ellie Paige, Ricardo C. Ferreira, et al.. (2017). Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma. Human Molecular Genetics. 26(8). 1584–1596. 39 indexed citations

15.

Zhao, Jing, et al.. (2016). Disrupted Endothelial Cell Layer and Exposed Extracellular Matrix Proteins Promote Capture of Late Outgrowth Endothelial Progenitor Cells. Stem Cells International. 2016(1). 1406304–1406304. 13 indexed citations

16.

Appleby, Sarah, Alexi Crosby, Kim Hoenderdos, et al.. (2016). Bone Morphogenetic Protein 9 Enhances Lipopolysaccharide-Induced Leukocyte Recruitment to the Vascular Endothelium. The Journal of Immunology. 197(8). 3302–3314. 20 indexed citations

17.

Soon, Elaine, Alexi Crosby, Mark Southwood, et al.. (2015). Bone Morphogenetic Protein Receptor Type II Deficiency and Increased Inflammatory Cytokine Production. A Gateway to Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 192(7). 859–872. 117 indexed citations

18.

Proudfoot, Alastair, Jatinder K. Juss, Sarah Appleby, et al.. (2014). S99 Effects Of Differential Tnf Receptor Signalling In Modulating Neutrophil-endothelial Interactions In The Pulmonary Microvasculature. Thorax. 69(Suppl 2). A53–A53. 2 indexed citations

19.

Ruzehaji, Nadira, Zlatko Kopecki, Elizabeth Melville, et al.. (2013). Attenuation of flightless I improves wound healing and enhances angiogenesis in a murine model of type 1 diabetes. Diabetologia. 57(2). 402–412. 30 indexed citations

20.

Appleby, Sarah, Jyotsna B. Pippal, Emma J. Thompson, et al.. (2012). Characterization of a Distinct Population of Circulating Human Non-Adherent Endothelial Forming Cells and Their Recruitment via Intercellular Adhesion Molecule-3. PLoS ONE. 7(11). e46996–e46996. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact